NRI.TO, NRIFF.PK Inked a deal with an industry titan for up to 100 million for their FDA pending topical anti-inflammatory medicine, Pennsaid. FDA ruling coming down in early August.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.